Last reviewed · How we verify
Metastatic ovarian carcinoma
Approved treatments
- Doxorubicin Hydrochloride · Pfizer Inc.
Doxorubicin intercalates nucleotide bases and interacts with topoisomerase II to form DNA-cleavable complexes, inhibiting DNA/RNA replication.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Metastatic ovarian carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Metastatic ovarian carcinoma treatment landscape brief
- Metastatic ovarian carcinoma treatment updates RSS
Frequently asked questions about Metastatic ovarian carcinoma
What drugs treat Metastatic ovarian carcinoma?
Tracked treatments include Doxorubicin Hydrochloride.
What is the treatment for Metastatic ovarian carcinoma?
Standard treatment for Metastatic ovarian carcinoma includes Doxorubicin Hydrochloride. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Metastatic ovarian carcinoma patent cliff · Metastatic ovarian carcinoma CI report
- Treatment: Doxorubicin Hydrochloride · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing